In line with these observations, MYH9 overexpression resulted in a significant reduction in GSK-3β expression in HNSCC cells, an effect that was largely counteracted by ACTN1 depletion (Fig. 5Q, Supplementary Fig. 9G). The gene discussed is MYH9; the disease is head and neck squamous cell carcinoma.